CTI BioPharma Stock Forecast

Stock Price Forecast

The 6 analysts with 12-month price forecasts for CTI BioPharma stock had an average target of $9.80, with a low estimate of $8.00 and a high estimate of $13.

Price Target: $9.80 (+7.81%)

Analyst Consensus: Buy

No price target forecast data available

Target	Low	Average	Median	High
Price	$8.00	$9.80	n/a	$13
Change	-11.99%	+7.81%	n/a	+43.01%

Analyst Ratings

The average analyst rating for CTI BioPharma stock from 6 stock analysts was "Buy". This means that analysts believed this stock was likely to outperform the market over the next twelve months.

Recommendation Trends

No data available

Rating	Oct 2026
Strong Buy	n/a
Buy	n/a
Hold	n/a
Sell	n/a
Strong Sell	n/a
Total	n/a

Financial Forecast

Revenue This Year

127.10M

from 53.95M

135.60%

from 53.95M

Revenue Next Year

257.94M

from 127.10M

102.94%

from 127.10M

EPS This Year

-0.28

from -0.81

EPS Next Year

0.40

from -0.28

Year	2018	2019	2020	2021	2022	2023	2024
Revenue	26.29M	3.35M	-	-	53.95M	127.10M	257.94M
Revenue Growth	4.55%	-87.28%	-	-	-	135.60%	102.94%
EPS	-0.52	-0.69	-0.74	-1.09	-0.81	-0.28	0.40
Forward PE	-	-	-	-	-	-	22.47
No. Analysts	-	-	-	-	-	11	11

Revenue Forecast

Revenue	2023	2024
High	146.6M	396.2M
Avg	127.1M	257.9M
Low	92.8M	142.0M

Revenue Growth

Revenue Growth	2023	2024
High	171.7%	211.7%
Avg	135.6%	102.9%
Low	72.0%	11.7%

EPS Forecast

EPS	2023	2024
High	-0.13	1.01
Avg	-0.28	0.40
Low	-0.48	-0.19

EPS Growth

EPS Growth	2023	2024
High	-	-
Avg	-	-
Low	-	-